MedPath

Evaluation of ramelteon for insomnia in patients with obstructive sleep apnea syndrome.

Not Applicable
Conditions
Insomnia in patients with obstructive sleep apnea syndrome.
Registration Number
JPRN-UMIN000025514
Lead Sponsor
Second Department of Internal Medicine, Nara Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient who already takes a sleeping drug 2) Patient who want to take a sleeping drug immediately

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Apnea hypopnea index after administration of ramelteon for 3 weeks
Secondary Outcome Measures
NameTimeMethod
Sleep latency after administration of ramelteon for 3 weeks
© Copyright 2025. All Rights Reserved by MedPath